SCHEMBL22954499

SCHEMBL22954499

CC(=O)COC1CCN(C)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
RAB9A P51151 1/20 0.41
MAPT P10636 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
SCN1A P35498 5/20 0.40
SCN2A Q99250 5/20 0.40
SCN3A Q9NY46 5/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
CHRM3 P20309 3/20 0.39
CHRM1 P11229 2/20 0.39
CHRM4 P08173 1/20 0.39
CHRM5 P08912 1/20 0.39
ATM Q13315 1/20 0.36
CYP1A2 P05177 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
MLNR O43193 1/20 0.35
CHRM2 P08172 1/20 0.35
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8336494 0.84 ALDH1A1 (0.45) ALDH1A1RAB9AMAPTSMN1; SMN2SCN1A
SCHEMBL12049806 0.82 ALDH1A1 (0.41) ALDH1A1RAB9AMAPTSMN1; SMN2SCN1A
SCHEMBL13867376 0.81 RAB9A (0.46) ALDH1A1RAB9AMAPTSMN1; SMN2SCN1A
SCHEMBL27429200 0.81 PAOX (0.41) ALDH1A1RAB9AMAPTSMN1; SMN2SCN1A
SCHEMBL16488085 0.80 ALDH1A1 (0.36) ALDH1A1RAB9AMAPTSMN1; SMN2SCN1A
SCHEMBL27397480 0.79 ALDH1A1 (0.39) ALDH1A1RAB9AMAPTSMN1; SMN2SCN1A
SCHEMBL12030708 0.79 HRH3 (0.40) KCNH2
SCHEMBL12312684 0.79 ATM (0.37) CHRM3ATMCHRM2
SCHEMBL18502887 0.79 CHRM3 (0.40) ALDH1A1RAB9AMAPTSMN1; SMN2SCN1A
SCHEMBL12049969 0.79 ALDH1A1 (0.39) ALDH1A1RAB9AMAPTSMN1; SMN2SCN1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024126617-A1 BIFUNCTIONAL COMPOUNDS FOR DEGRADING KINASES VIA UBIQUITIN PROTEOSOME PATHWAY CROSSFIRE ONCOLOGY HOLDING B.V. (NL) 2024-06-20 WO disclosed
WO-2021018118-A1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 1 PROTEINS JANSSEN PHARMACEUTICA NV (BE) 2021-02-04 WO disclosed